Liquidia (LQDA) EV to EBIT (2019 - 2026)

Liquidia (LQDA) EV to EBIT (2019 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to EBIT
1	Teva Pharmaceutical Industries	38.67 Bn	34.93 Bn	1.97 Bn	15.26
2	Zoetis	30.59 Bn	28.65 Bn	1.62 Bn	7.83
3	RedHill Biopharma	26.22 Bn	26.22 Bn	-	-3,301.58
4	United Therapeutics	23.80 Bn	21.65 Bn	648.10 Mn	15.08
5	Curaleaf Holdings	23.70 Bn	23.70 Bn	157.29 Mn	1,289.58
6	Viatris	18.69 Bn	16.89 Bn	1.16 Bn	121.16
7	Neurocrine Biosciences	16.86 Bn	15.54 Bn	800.70 Mn	19.70
8	Elanco Animal Health	11.99 Bn	11.57 Bn	785.00 Mn	13.56
9	Dr Reddys Laboratories	11.65 Bn	11.51 Bn	-	19.87
10	Liquidia	6.98 Bn	6.76 Bn	121.79 Mn	148.35

Download Data